Negatol (Policresulen) is a topical hemostatic and antiseptic indicated for common anal disorders, such as hemorrhoids, and for gynecological infections. Policresulen has hemostatic activity by causing coagulation of blood proteins and promoting the contraction of the muscular fibers of the blood vessels of small caliber. Policresulen promotes selective chemical debridement: being an anion, it has the ability to interact only with the phospholipid molecules of the plasma membranes of to devitalized cells, which have lost its original electric charge. This contact provides the denaturation of cellular proteins, facilitating their removal. Its acidity, together with coagulating properties, give policresulen antimicrobial activity against staphylococcus spp., streptococcus spp. and Candida albicans. Policresulen is often used for gynecological infections. It is also used to treat canker sore in some countries.
Approval Year
| Substance Class |
Polymer
Created
by
admin
on
Edited
Mon Mar 31 22:52:23 GMT 2025
by
admin
on
Mon Mar 31 22:52:23 GMT 2025
|
| Record UNII |
6I19M5GB0G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QG01AX03
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
||
|
WHO-VATC |
QD08AE02
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
||
|
WHO-ATC |
D08AE02
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
||
|
WHO-VATC |
QG51AD02
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
||
|
WHO-ATC |
G01AX03
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6I19M5GB0G
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
m8943
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID70143913
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
4691
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
101418-00-2
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106937
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
100000092511
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
6I19M5GB0G
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
DB13492
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
5952
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
POLICRESULEN
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
SUB09966MIG
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | |||
|
54908
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY | RxNorm | ||
|
C166940
Created by
admin on Mon Mar 31 22:52:23 GMT 2025 , Edited by admin on Mon Mar 31 22:52:23 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE |